News | Chiesi Farmaceutici S.p.A.

Home > News

ISO 37001:2016 Certification: Chiesi Farmaceutici Starts the Extension Process of the Certification...

ISO 37001:2016 Certification: Chiesi Farmaceutici Starts the Extension Process of the Certification to the Affiliates of the Group As part of our commitment to preventing bribery and in accordance...

LEED Certification: Sustainable Workspaces for People and the Planet

In Memory of Dr. Paolo Chiesi: Visionary Leader and Innovator

ARCHIVE NEWS

Global Corporate Development : opening of new offices in Boston

16 March 2018

Chiesi enters into an Exclusive ex-US Partnership with Protalix BioTherapeutics for the Development and Commercialization of PRX-102 (pegunigalsidase alfa) for the Treatment of Fabry Disease

20 October 2017

Chiesi Digital Transformation - Digital Safari Workshop with David Orban

24 January 2018

Chiesi certified Top Employer also for 2017

13 February 2017

Alberto, Paolo and Andrea Chiesi winners of the “Entrepreneur of the year 2015” Award

30 November 2015

Special Mention to Holoclar at the Italian Galeno Award

26 November 2015

Chiesi is Top Employer again!

15 February 2016

COPD indication for Foster pMDI

21 March 2014

Double-digit growth and internal expansion for the Chiesi Group

14 March 2014

<< 1 2 3 4 5 6 7 8 9

© 2025 CHIESI Farmaceutici S.p.A.

VAT IT 01513360345
Company's Capital: Euro 75.000.000
Companies Register Office - Parma N.15739
REA: 159271

PHARMACOVIGILANCE

TO REPORT ADVERSE DRUG EVENTS/REACTIONS PLEASE CLICK HERE

follow us on: